We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Philips to Acquire Leading Brazilian Critical Care Company

By HospiMedica staff writers
Posted on 13 May 2008
Print article
In a move that further bolsters its strategy of penetrating high-growth emerging critical care markets by way of economically priced devices, Netherlands-based Royal Philips Electronics announced its agreement to acquire Dixtal Biomédica e Tecnologia, a leading Brazilian manufacturer of patient monitoring and critical care devices.

Dixtal (São Paulo, Brazil) is a leading Brazilian manufacturer of in-hospital patient monitoring, anesthesia, ventilation, and ECG (Electrocardiogram) equipment as well as other sensors for vital sign measurements. Dixtal will become part of the Patient Monitoring business within Philips' Healthcare sector. Philips expects Dixtal's financial results to be consolidated as of the third quarter of 2008. The terms of the deal were not disclosed.

The announcement marks another step Philips (Amsterdam, The Netherlands) is taking to expand its presence in high-growth healthcare markets in emerging economies, following the company's earlier announced acquisitions of healthcare companies Shenzhen Goldway in China and VMI Sistemas Medicos in Brazil.

In commenting on the deal, Mr. Daurio Speranzini Júnior, Senior Vice-President of Philips Healthcare Latin America, said: "Emerging markets represent a real opportunity for us to keep growing our healthcare business at Philips. If you just take Latin America, our segment of the healthcare market in 2007 was estimated to be valued at approximately EUR 1.2 billion, and growing at twice the rate of developed markets. Acquiring Dixtal will help us further tap into that growth.”

Mr. Speranzini Júnior continued, "In the hospital, a key component of critical care is patient monitoring, and Philips already enjoys a leading global position in this market. Acquiring Dixtal will not only extend Philips' product portfolio to include Dixtal's mid- to economy-range patient monitoring products, but through this move we'll gain access to other key components of critical care – Dixtal's anesthesia machines and its invasive ventilation products. Accordingly, this acquisition complements Philips' recent move into the non-invasive ventilation business through our acquisition earlier this year of US-based Respironics. And since Dixtal and Philips use the same distribution channels vis-à-vis hospitals for all of our critical care businesses, we can expect significant synergies coming out of this collaboration.”

Founded in 1978, Dixtal is a privately held healthcare company headquartered in São Paulo, Brazil. Dixtal employs approximately 300 people, mainly in Brazil, of which 60 work in R&D. "Since being founded 30 years ago, we've focused on helping hospitals provide the optimum in critical care. We believe that combining our culture and capabilities with those of a world class company like Philips will help us serve society better and expand our presence in Latin America and beyond,” said Albert Holzhacker, President of Dixtal.

Over the last four years, Dixtal has tripled its revenues. Following completion of the acquisition, growth is expected to accelerate further as Philips leverages Dixtal's contacts with local hospitals and distributors, while Dixtal capitalizes on Philips' global presence for its products.

Philips has an extensive presence in critical care through its leading position in the global patient monitoring market, which in 2007 was estimated at approximately EUR 2 billion.


Related Links:
Dixtal
Philips
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Transducer Covers
Surgi Intraoperative Covers
New
Transcatheter Heart Valve
SAPIEN 3 Ultra

Print article

Channels

Surgical Techniques

view channel
Image: The new treatment combination for subdural hematoma reduces the risk of recurrence (Photo courtesy of Neurosurgery 85(6):801-807, December 2019)

Novel Combination of Surgery and Embolization for Subdural Hematoma Reduces Risk of Recurrence

Subdural hematomas, which occur when bleeding happens between the brain and its protective membrane due to trauma, are common in older adults. By 2030, chronic subdural hematomas are expected to become... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.